A report was recently published by Market Research Future (MRFR) assessing the dynamics in the global facial injectors market over the forecast period of 2018-2023. The facial injectors market is set to march on the growth trajectory at a CAGR of 11.12%, garnering a revenue valuation of USD 14571.47 million by the end of the forecast period. Various attributable factors to the growth of the facial injectors market are studied in the MRFR report.
Booming of the entertainment industry and increased popularity of celebrity culture is affecting the lifestyle choices of the urban population and elevating bars of beauty standard measurements. Proliferating research and development for advanced aesthetic injectors, along with a growing demand for anti-aging and other beauty treatments in many emerging countries are attributed to the mounting growth of the facial injectors market over the assessment period.
Incorporation of advanced technologies in the healthcare sector has contributed heavily to the improved provision of procedures in cosmetic surgery and facial aesthetic treatment. Ascension in the preference towards minimally invasive treatments, coupled with the rising popularity of facial aesthetic treatments is estimated to fuel demand for facial injectors, driving the facial injectors market.
Key Players
Some of the significant players profiled by MRFR that are operating in the global facial injectors market are SciVision Biotech Inc, Ipsen Pharma. Merck KGaA, Sanofi, Revance Therapeutics Inc., Sinclair Pharma, Galderma S.A., Suneva Medical Inc., Merz Pharma, Valeant Pharmaceuticals, Allergan, and Integra LifeSciences Corporation.
Market Segmentation
The global facial injectors market report also has analysis carried out on a segmental basis. This includes the different types of facial injectors, several applications of these facial injectors, and end-users.
- By Types of facial injectors studied in the report include types of anti-aging/anti-wrinkle injections and dermal fillers/injectable implants.
- By Applications of facial injectors are face-lift and facial line correction treatment and lip treatment.
- By End-users of facial injectors include hospitals, and dermatology clinics & cosmetic centers.
Detailed Regional Analysis
The global facial injectors market is regionally segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.
Americas is expected to lead the market with a valuation of USD 4,093.0 million in 2019. The regional market value is projected to reach USD 8,551.9 million by 2027 at a 9.65% CAGR during the forecast period. The US and Canada are the key country-level markets in the Americas. The regional market growth is primarily attributed to the high demand for facial treatments in the region, which is likely to create additional opportunities for the service providers operating in the facial injectors market in the Americas.
Europe is expected to be the second-largest market with an estimated value of USD 2,995.8 million in 2019 and a projected value of USD 6,420.7 million by 2027, registering a 10.0% CAGR during the forecast period. The European facial injectors market includes the UK, Germany, France, Italy, and the Rest of Europe. Prominent players such as Galderma S.A., Merz Pharma, Sinclair Pharma, Sanofi, and Ipsen Pharma are driving market growth in the region. Moreover, due to the increasing number of face-lifts and lip treatments, there will likely be an increased requirement for facial injectors in the region.
The Asia-Pacific accounted for the third-largest market share in 2019. The region is expected to be the fastest-growing market for facial injectors during the review period. The Asia-Pacific facial injectors market covers China, Japan, India, Australia, and the rest of Asia-Pacific. The region is gaining prominence in the global healthcare industry and is projected to become the world’s leading market. Additionally, the increasing demand for facial treatments in the region is expected to drive the regional market's growth. The regional facial injectors market is expected to reach USD 3,666.1 million by 2027.
The Middle East & Africa is expected to reach a valuation of USD 1,016.7 Million by 2027. The regional market growth is significantly driven by the presence of major countries, such as the UAE, Saudi Arabia, and Israel. The region has witnessed notable economic growth in the past few years. One of the major factors driving the economy in the region is enhanced healthcare facilities. The demand for facial injectors is expected to increase due to the rapid increase in the number of face-lift and lip treatments in the region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
